Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Tereza Lanitis"'
Autor:
Jason G. Andrade, MD, Anshul Shah, BS Pharm, MS, Richard Godin, PhD, Tereza Lanitis, MSc, Thitima Kongnakorn, PhD, Lauren Brown, BSc, Devender Dhanda, PhD, MBA, Amol Dhamane, BPharm, MS, Isabelle Nault, MD
Publikováno v:
Heart Rhythm O2, Vol 4, Iss 2, Pp 103-110 (2023)
Background: Contemporary guidelines recommend opportunistic screening for atrial fibrillation (AF). Objective: The objective of this study was to assess the cost-effectiveness of single time point opportunistic AF screening for patients 65 years and
Externí odkaz:
https://doaj.org/article/13f5ad49a46d48eeb82a03096831da8c
Publikováno v:
Future Oncology. 15:4057-4067
Aim: To conduct a value assessment of an immuno-oncology (IO) therapy for a rare cancer and evaluate whether existing frameworks consider challenges associated with valuing IOs for rare cancers. Materials & methods: Value frameworks developed by Amer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edba19a22c132bb99a28ff931f88060
https://doi.org/10.2217/fon-2019-0456
https://doi.org/10.2217/fon-2019-0456
Autor:
Andreas Kuznik, Andrea Gibson, Tereza Lanitis, Andrew A. Moshfeghi, Jonathan L. Prenner, Georg Kropat, Haidong Feng
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 51
BACKGROUND AND OBJECTIVE: To estimate the social cost of blindness due to wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and proliferative diabetic retinopathy (PDR) in the United States in 2020. PATIENTS AND METHODS: Exce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a970388e6ecdf615cc890b68631eb9b
https://doi.org/10.3928/23258160-20200401-01
https://doi.org/10.3928/23258160-20200401-01
Publikováno v:
Journal of managed carespecialty pharmacy. 24(7)
Age-related macular degeneration (AMD) is the leading cause of vision loss in the United States. The most severe vision loss occurs in patients with neovascular AMD, known as wet AMD (wAMD). The most commonly used antivascular endothelial growth fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8267458c6f1c6a5abc3aeaf79e9bce50
https://pubmed.ncbi.nlm.nih.gov/29952707
https://pubmed.ncbi.nlm.nih.gov/29952707
Publikováno v:
Multi-Criteria Decision Analysis to Support Healthcare Decisions ISBN: 9783319475387
A key component of many multi-criteria decision analyses (MCDAs) is the elicitation of stakeholder preferences in the form or scores and weights. A challenge to the MCDA practitioner is that there is little guidance about how to choose between the ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be7427139f02ecd4adbb9bebb466ddb0
https://doi.org/10.1007/978-3-319-47540-0_4
https://doi.org/10.1007/978-3-319-47540-0_4
Autor:
Vincent Thijs, Lieven Annemans, Jean-Claude Wautrecht, Tereza Lanitis, Sophie Marbaix, Marnix Goethals, Thitima Kongnakorn
Publikováno v:
Clinical Drug Investigation. 35:109-119
Management of non-valvular atrial fibrillation (NVAF) focuses on the use of anticoagulation to mitigate the risk of stroke. Until recently, vitamin K antagonist (VKA) treatment was considered the standard of care, with the emergence of non-VKA oral a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e9cb8711dd70630915d939b6fb6e2a
https://doi.org/10.1007/s40261-014-0253-7
https://doi.org/10.1007/s40261-014-0253-7
Autor:
Thitima, Kongnakorn, Tereza, Lanitis, Annemans, Lieven, Lievens, Annemans, Vincent, Thijs, Sophie, Marbaix
Publikováno v:
Clinical Drug Investigation. 34:709-721
Evidence indicates that vitamin K antagonists (VKAs) and oral anticoagulant therapy are under-utilised for stroke prevention in patients with non-valvular atrial fibrillation (AF), and patients who decline or cannot tolerate such treatment are often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4673e45a216a4799fd32e5d884a5fe9
https://doi.org/10.1007/s40261-014-0224-z
https://doi.org/10.1007/s40261-014-0224-z
Autor:
Alexander T. Cohen, Melissa Hamilton, Dale Rublee, Chantelle Browne, Robert Leipold, Tereza Lanitis, Peter Quon
Publikováno v:
BMC Health Services Research
Background Prior analyses beyond clinical trials are yet to evaluate the projected lifetime benefit of apixaban treatment compared to low-molecular-weight heparin (LMWH)/vitamin K antagonist (VKA) for treatment of venous thromboembolism (VTE) and pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d109d9fe99c551eac771ae938720c7
https://pubmed.ncbi.nlm.nih.gov/28114939
https://pubmed.ncbi.nlm.nih.gov/28114939
Autor:
Ruth Pettengell, Anthony J. Hatswell, Jack W. Singer, Ananth Kadambi, Dilip Patel, Noemi Muszbek, Tereza Lanitis, Lixia Wang
Publikováno v:
Clinical therapeutics. 38(3)
Purpose Aggressive non-Hodgkin’s lymphoma (aNHL) is associated with poor long-term survival after relapse, and treatment is limited by a lack of consensus regarding standard of care. Pixantrone was studied in a randomized trial in patients with rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba28cc0e46ce184ef4e0e31604584e01
https://pubmed.ncbi.nlm.nih.gov/26856929
https://pubmed.ncbi.nlm.nih.gov/26856929
Autor:
Hemant Phatak, Thitima Kongnakorn, Tereza Lanitis, Jack Mardekian, Paul Dorian, Gregory Y.H. Lip
Publikováno v:
Lip, G Y H, Lanitis, T, Mardekian, J, Kongnakorn, T, Phatak, H & Dorian, P 2015, ' Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients ', Stroke, vol. 46, no. 10, pp. 2830-2837 . https://doi.org/10.1161/STROKEAHA.115.009995
Background and Purpose— Although recommended by guidelines, the benefits of treating patients with atrial fibrillation with a low–stroke risk score, with aspirin or anticoagulants, have not been clearly established. With advent of safer non–vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff72b420fea0eebb7a06f9b049ce14e
https://vbn.aau.dk/da/publications/bc43e746-dd89-4e84-bacc-e1470fa54315
https://vbn.aau.dk/da/publications/bc43e746-dd89-4e84-bacc-e1470fa54315